BTBD9 Antikörper (AA 237-262)
Kurzübersicht für BTBD9 Antikörper (AA 237-262) (ABIN651859)
Target
Alle BTBD9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 237-262
-
Homologie
- B
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This BTBD9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 237-262 amino acids from the Central region of human BTBD9.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Haltbarkeit
- 6 months
-
-
- BTBD9 (BTB (POZ) Domain Containing 9 (BTBD9))
-
Andere Bezeichnung
- BTBD9
-
Hintergrund
- This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome.
-
Molekulargewicht
- 69188
-
Gen-ID
- 114781
-
NCBI Accession
- NP_001092742, NP_001165889, NP_443125, NP_689946
-
UniProt
- Q96Q07
-
Pathways
- Transition Metal Ion Homeostasis
Target
-